Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection.
We investigated the possible mechanisms of paralysis and recovery in a patient with the acute motor axonal neuropathy (AMAN) pattern of the Guillain-Barré syndrome. The AMAN pattern of GBS is characterized clinically by acute paralysis without sensory involvement and electrodiagnostically by low compound motor action potential amplitudes, suggesting axonal damage, without evidence of demyelination. Many AMAN patients have serologic or culture evidence of recent Campylobacter jejuni infection. Pathologically, the most severe cases are characterized by wallerian-like degeneration of motor axons affecting the ventral roots as well as peripheral nerves, but some fatal cases have only minor changes in the roots and peripheral nerves, and some paralyzed patients with the characteristic electrodiagnostic findings of AMAN recover rapidly. The mechanism of paralysis and recovery in such cases has been uncertain. A 64-year-old woman with culture-proven Campylobacter upsaliensis diarrhea developed typical features of AMAN. She improved quickly following plasmapheresis. Her serum contained IgG anti-GM1 antibodies. The lipopolysaccharide of the organism bound peanut agglutinin. This binding was blocked by cholera toxin, suggesting that the organism contained the Gal(beta1-3)GalNAc epitope of GM1 in its lipopolysaccharide. Motor-point biopsy showed denervated neuromuscular junctions and reduced fiber numbers in intramuscular nerves. In contrast, the sural nerve biopsy was normal and skin biopsy showed normal dermal and epidermal innervation. In AMAN the paralysis may reflect degeneration of motor nerve terminals and intramuscular axons. In addition, the anti-GM1 antibodies, which can bind at nodes of Ranvier, might produce failure of conduction. These processes are potentially reversible and likely to underlie the capacity for rapid recovery that characterizes some cases of AMAN.
Ho
T W
TW
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Hsieh
S T
ST
Nachamkin
I
I
Willison
H J
HJ
Sheikh
K
K
Kiehlbauch
J
J
Flanigan
K
K
McArthur
J C
JC
Cornblath
D R
DR
McKhann
G M
GM
Griffin
J W
JW
D001706:Biopsy; D002167:Campylobacter / Q000276:immunology / Q000302:isolation & purification; D002169:Campylobacter Infections / Q000150:complications* / Q000503:physiopathology; D003967:Diarrhea / Q000150:complications / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D015151:Immunoblotting; D008475:Median Nerve / Q000503:physiopathology; D008854:Microscopy, Electron; D008875:Middle Aged; D016472:Motor Neuron Disease / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D009431:Neural Conduction / Q000502:physiology; D009469:Neuromuscular Junction / Q000648:ultrastructure; D010543:Peroneal Nerve / Q000503:physiopathology; D010956:Plasmapheresis; D011129:Polyradiculoneuropathy / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D017729:Presynaptic Terminals; D012867:Skin / Q000294:innervation / Q000473:pathology; D013497:Sural Nerve / Q000473:pathology; D014459:Ulnar Nerve / Q000503:physiopathology; D014855:Wallerian Degeneration / Q000502:physiology